Camarda Financial Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-12
Closed 365
2019
Q2
$0 Hold
12
﹤0.01% 561
2019
Q1
$0 Hold
12
﹤0.01% 557
2018
Q4
$0 Hold
12
﹤0.01% 218
2018
Q3
$0 Hold
12
﹤0.01% 241
2018
Q2
$0 Hold
12
﹤0.01% 189
2018
Q1
$0 Hold
12
﹤0.01% 188
2017
Q4
$0 Hold
12
﹤0.01% 215
2017
Q3
$1K Hold
12
﹤0.01% 203
2017
Q2
$1K Hold
12
﹤0.01% 232
2017
Q1
$1K Hold
12
﹤0.01% 169
2016
Q4
$1K Hold
12
﹤0.01% 245
2016
Q3
$1K Hold
12
﹤0.01% 206
2016
Q2
$0 Hold
12
﹤0.01% 295
2016
Q1
$0 Hold
12
﹤0.01% 300
2015
Q4
$1K Hold
12
﹤0.01% 226
2015
Q3
$1K Hold
12
﹤0.01% 162
2015
Q2
$1K Sell
12
-5
-29% -$197 ﹤0.01% 212
2015
Q1
$1K Hold
17
﹤0.01% 239
2014
Q4
$0 Hold
17
﹤0.01% 280
2014
Q3
$0 Hold
17
﹤0.01% 241
2014
Q2
$0 Hold
17
﹤0.01% 230
2014
Q1
$1K Buy
+17
New +$548 ﹤0.01% 193

Other funds holding PRTA

Camarda Financial Advisors's PRTA Position: Q3 2019 in Review

Camarda Financial Advisors sold out of Prothena Corp (PRTA) in Q3 2019, closing a stake of 12 shares.

Camarda Financial Advisors first reported a position in PRTA in Q1 2014 and held it in 22 quarters. The position peaked at $1K in Q3 2017. 130 funds tracked by Wall St. Rank hold PRTA as of Q3 2019.

  • Camarda Financial Advisors reported no remaining Prothena Corp position as of Q3 2019 after selling out during the quarter.
  • Camarda Financial Advisors sold 12 Prothena Corp shares in Q3 2019.
  • Camarda Financial Advisors first reported a position in Prothena Corp in Q1 2014 and held it in 22 quarters.
  • Camarda Financial Advisors's Prothena Corp position peaked at $1K in Q3 2017.
  • 130 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2019.

Based on Camarda Financial Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.